glp-1 and bipolar Exploring Agonists: Adjunct Treatment For Disorder GLP-1 Anti-Obesity Rx and Alcohol

While most patients adapt within 36 months, some experience diarrhea that continues or emerges after a full year of treatment

And always: GLP-1 first, basics second, peptides third

Novo Nordisk and Lilly share the bulk of the market, while other market watchers believe the overall value can go even higher

doi: 10.1001/jamainternmed.2024.4369 [DOI] [PMC free article] [PubMed] [Google Scholar] 18

If the drugs are directly both improving weight reduction and cancer reduction, then we need to double down. Ganta wonders the same thing about the drugs apparent positive effects on several conditions, from dementia to sleep apnea: Is it that obesity is causing or contributing to the problem [and that weight loss is causing the improvement], or is the medication directly having an impact through a different mechanism? She hopes there will be more research to parse this out in the years to come